Clinical Trial Update: Stereotactic Radiotherapy for Cerebral Metastases with Recent Hemorrhagic Signal [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating stereotactic radiotherapy for hemorrhagic brain metastases is currently recruiting, sponsored by Centre Francois Baclesse.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Hemorrhagic Brain Metastases

Snippet

Sponsor: Centre Francois Baclesse | Conditions: Hemorrhagic Brain Metastases | Phase 2 | Status: RECRUITING